Conducting Assay, Purity profile, and Dissolution rate for Decitabine Capsules

Information

• Research Project
• 9568966

• ApplicationId

  9568966

• Core Project Number

  N02CA000000

• Full Project Number

  261201500009I-0-26100023-1

• Serial Number

• FOA Number

• Sub Project Id

• Project Start Date

  8/15/2017 - 7 years ago

• Project End Date

  2/15/2018 - 7 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2017

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• IRISYS, INC.

The contractor will conduct assay, purity profile, and dissolution rate on the Dicitabine capsule (capsules will be provided by NCI/CC Pharmacy) based on the methods used for releasing the Decitabine capsules. The tests should be done under the cGMP condition.

IC Name

• Activity

  N02

• Administering IC

  CA

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  8280

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

• Ed Inst. Type

• Funding ICs

  NCI:8280\

• Funding Mechanism

  Non SBIR/STTR Contracts

• Study Section

• Study Section Name

• Organization Name

  IRISYS, INC.

• Organization Department

• Organization DUNS

  079682716

• Organization City

  SAN DIEGO

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  92121

• Organization District

  UNITED STATES